Sudan Loganathan
Stock Analyst at Stephens & Co.
(0)
# 4851
Out of 5,329 analysts
35
Total ratings
25.93%
Success rate
-26.54%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ELEV Elevation Oncology | Downgrades: Equal-Weight | 5 5 | 0.34 | 1370.59% | 4 | Mar 24, 2025 | |
IMNM Immunome | Reiterates: Overweight | 30 30 | 9.07 | 230.76% | 2 | Mar 20, 2025 | |
CPRX Catalyst Pharmaceuti... | Reiterates: Overweight | 33 33 | 24.91 | 32.48% | 2 | Feb 27, 2025 | |
ADCT ADC Therapeutics | Maintains: Overweight | 6 8 | 1.48 | 440.54% | 2 | Feb 24, 2025 | |
IDYA IDEAYA Biosciences | Reiterates: Overweight | 50 50 | 21.3 | 134.74% | 2 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 29 29 | 39.17 | -25.96% | 4 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 15 15 | 9.43 | 59.07% | 2 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 31 31 | 11.27 | 175.07% | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 60 60 | 35.96 | 66.85% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 140 140 | 101.69 | 37.67% | 2 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.61 | 210.56% | 2 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 4 | 1.7 | 135.29% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 6.99 | 686.84% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 1.22 | 965.57% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 25 25 | 12.26 | 103.92% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 0.4 | 1150% | 2 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | 1.93 | 936.27% | 1 | May 14, 2024 |